Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy Rui M. L. CoelhoReno DebetsDora Hammerl Review Open access 16 October 2025 Article: 261
Targeting metalloptosis in tumor therapy: from molecular mechanisms to application of metal nanoparticles Jinxiang WangQin TianYihang Pan Review Open access 16 October 2025 Article: 260
Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models Liwei DuZicheng ZhengHuayu Yang Research Open access 14 October 2025 Article: 259
Reversal of tumour immune evasion via enhanced MHC-Class-I antigen presentation by a dual-functional RNA regulated system Chaoyang MengHuipeng ZhangQi Ling Research Open access 14 October 2025 Article: 258
Harnessing ovarian cancer ascites for translational science: models, biomarkers, and therapeutics Samrita DograLaura AdhikariBethany N. Hannafon Review Open access 14 October 2025 Article: 257
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth Aleksandra FesiukDaniel PölöskeLukas Kenner Research Open access 14 October 2025 Article: 256
Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissues Mengjie YuCheng LiuWei Zhu Research Open access 14 October 2025 Article: 255
Turning cold tumors into hot tumors to ignite immunotherapy Yuan-Tong LiuYun-Long WangXiang-Bo Wan Review Open access 14 October 2025 Article: 254
Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach Zaira IannielloHuimei LuPeter M. Glazer Research Open access 13 October 2025 Article: 253
Medical importance and pharmacokinetics of gold nanoparticles in the human body Priyanka SinghAbhayraj S. JoshiIvan Mijakovic Research Open access 10 October 2025 Article: 252
Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications Yubo YanShuang LiuRong Ma Review Open access 09 October 2025 Article: 251
Emerging role of cancer-associated fibroblasts in the premetastatic niche Shuaixi YangYing GuoYing Liu Review Open access 08 October 2025 Article: 250
Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy Huiru ZhangJialiang FanHaizeng Zhang Review Open access 08 October 2025 Article: 249
Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers Sarvesh Kumar MishraTapojyoti SanyalAmlan Das Review Open access 08 October 2025 Article: 248
Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling Shouhua LiHengtong HanYong-xun Zhao Review Open access 08 October 2025 Article: 247
Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions Kartik MandalGanesh Kumar BarikManas Kumar Santra Review Open access 08 October 2025 Article: 246
MALAT1 as a molecular driver of tumor progression, immune evasion, and resistance to therapy Amirreza BitarafAlireza ZafaraniSadegh Babashah Review Open access 06 October 2025 Article: 245
Non-coding RNAs in gastric cancer: mechanisms and therapeutic prospects Zhifei HanWenjuan LiuMing Yang Review Open access 03 October 2025 Article: 244
A circRNA promotes esophageal squamous cell carcinoma progression by inhibiting TRIM25-mediated degradation of IGF2BP family members Shuangyan TanYue MingYong Peng Research Open access 03 October 2025 Article: 243
Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis Xuanyu RenMei Song Weiling He Review Open access 03 October 2025 Article: 242
HPGD induces ferroptosis and autophagy to suppress esophageal squamous cell carcinoma through the LXA4–ERK1/2–U2AF2–TFRC axis Tianyun MaXiamei GuoChao Luo Research Open access 02 October 2025 Article: 241
Microbiome-metabolome interplay in pancreatic cancer progression: insights from multi-omics analysis Dong LuoQizhen ChenXuejun Gong Research Open access 02 October 2025 Article: 240
BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer Qingqing ZhouQi WangZhihuang Hu Research Open access 02 October 2025 Article: 239
Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization Zhongyuan WangQintao GeXiaojian Qin Research Open access 02 October 2025 Article: 238
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy Huiting YangDong LiuJi Zhu Review Open access 02 October 2025 Article: 237
Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting Qing DengYu JiTao Wen Review Open access 02 October 2025 Article: 236
P23 acts as a negative regulator of ferroptosis in NSCLC by blocking GPX4 degradation via chaperone-mediated autophagy Junlin ChenYulin PengXiaochi Ma Research Open access 02 October 2025 Article: 234
Decoding the ubiquitin network: molecular mechanisms and therapeutic vulnerabilities for precision radio-sensitization in cancer Fu-Ying ZhaoLi-Ye ShiHua-Qin Wang Review Open access 02 October 2025 Article: 233
Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study Yunxin LuQingguang LinDongsheng Zhang Research Open access 02 October 2025 Article: 235
​​The immune microenvironment of pathogen-associated cancers and current clinical therapeutics Xiao-Yu WeiHui-Jing FengQi Mei Research Open access 02 October 2025 Article: 232
The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets Chunyu ZhangXiangdong GuoZhihua Wang Review Open access 30 September 2025 Article: 231
Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance Fei DuLu TangZhuo Zhang Review Open access 25 September 2025 Article: 230
Multifunctional gold nanoparticles: bridging detection, diagnosis, and targeted therapy in cancer Lianting ZhuangYi LianTiantong Zhu Review Open access 24 September 2025 Article: 228
Evolution of direct RAS inhibitors: from undruggable target to clinical breakthroughs Xia WangJing WuJun Tian Review Open access 24 September 2025 Article: 229
Retraction Note: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer Jianan ChenYan YuRanran Sun Retraction Note Open access 05 September 2025 Article: 227
Correction: Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development Guoming ChenBonan ChenYibin Feng Correction Open access 04 September 2025 Article: 226
Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics Chao YangShenglong LiLiming Wang Review Open access 01 September 2025 Article: 225
Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis Zhengjun JingWenqin HuangYalong Yang Review Open access 27 August 2025 Article: 224
Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling Bo TangYihua YangFumio Shimamoto Retraction Note Open access 26 August 2025 Article: 223
The application of organoids in treatment decision-making for digestive system cancers: progress and challenges Yufei WangLimin ZhangBoon-Cher Goh Review Open access 25 August 2025 Article: 222
Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment Jiayuan LeYating DianGuangtong Deng Review Open access 25 August 2025 Article: 221
Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities Lan HuZikun HuangYing Zhang Review Open access 23 August 2025 Article: 220
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers Xisong LiangJiadi WengQuan Cheng Review Open access 22 August 2025 Article: 219
CircZFR/YTHDF3 axis drives lymph node metastasis in cervical cancer via FASN translation Mingyi ZhouYan GaoDanbo Wang Research Open access 21 August 2025 Article: 218
Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer Xin PengYingying WangDexin Kong Research Open access 16 August 2025 Article: 217
Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors Jiyuan YangYu WuXudong Wang Review Open access 11 August 2025 Article: 216
Integrating neuroscience and oncology: neuroimmune crosstalk in the initiation and progression of digestive system tumors Haonan SunTao WangZuoyi Jiao Review Open access 10 August 2025 Article: 215
CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance Christophe Nicot Editorial Open access 10 August 2025 Article: 214
Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics Tiejun FengFuda XieWei Kang Review Open access 08 August 2025 Article: 213
Bispecific antibodies: unleashing a new era in oncology treatment Lin ShuiDan WuRutie Yin Review Open access 04 August 2025 Article: 212